Showing results (61-70 of 76) with videos related to

Sort By:
Pageof 8
Acta Neuropathologica|January 1, 1987
Photochemically induced cerebral infarction. II. Edema and blood-brain barrier disruptionW D Dietrich, R Busto, B D Watson, et al.
Stroke|March 1, 1976
XIII. Cerebral circulation and metabolism in stroke. Cerebral circulation and metabolism in stroke study groupP Scheinberg, J S Meyer, M Reivich, et al.
Clinical and Experimental Immunology|April 24, 2013
Thymus transplantation restores the repertoires of forkhead box protein 3 (FoxP3)+ and FoxP3- T cells in complete DiGeorge anomalyI K Chinn, J D Milner, P Scheinberg, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|December 1, 1987
Small differences in intraischemic brain temperature critically determine the extent of ischemic neuronal injuryR Busto, W D Dietrich, M Y Globus, et al.
Lupus|September 1, 2006
Antinucleosome antibodies in patients with juvenile systemic lupus erythematosusL M A Campos, M H B Kiss, M A Scheinberg, et al.
Clinical and Experimental Rheumatology|January 17, 2002
Serum vascular endothelial growth factor in late rheumatoid arthritisG R Pinheiro, C A Andrade, C R Gayer, et al.
Neurology|February 1, 1983
Compression-induced brain edema: modification by prior depletion and supplementation of vitamin ES Yoshida, R Busto, M D Ginsberg, et al.
Lupus|December 1, 1994
Anticardiolipin antibodies in infections are heterogenous in their dependency on beta 2-glycoprotein I: analysis of anticardiolipin antibodies in leprosyM Hojnik, B Gilburd, L Ziporen, et al.
Revista Do Instituto De Medicina Tropical De Sao Paulo|March 1, 1996
Immunological status of ENL (erythema nodosum leprosum) patients: its relationship to bacterial load and levels of circulating IL-2RL M Vieira, E P Sampaio, J A Nery, et al.
Annals of the Rheumatic Diseases|April 22, 2014
A phase 2, randomised, placebo-controlled clinical trial of blisibimod, an inhibitor of B cell activating factor, in patients with moderate-to-severe systemic lupus erythematosus, the PEARL-SC studyR A Furie, G Leon, M Thomas, et al.
Pageof 8